| Kari E Roberts, MD | |
|
800 Washington St # 257, Boston, MA 02111-1552 | |
| (617) 636-5513 | |
| (617) 636-5953 |
| Full Name | Kari E Roberts |
|---|---|
| Gender | Female |
| Speciality | Pulmonary Disease |
| Experience | 27 Years |
| Location | 800 Washington St # 257, Boston, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427096726 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 223140 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tufts Medical Center | Boston, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pratt Medical Group Inc | 3375515661 | 265 |
News Archive
As increased regulatory compliance and pay-for-performance models are leading to higher requirements for electronic data collection and professional fee billing of surgery-related procedures, Merge Healthcare, has responded with new anesthesia information management solutions (AIMS), which will be on display at the American Society of Anesthesiologists (ASA) 2009 Annual Meeting.
Study of 5,392 adults found that a quarter had quit their overactive bladder medication, with nine out of ten saying it didn't work as expected or they couldn't tolerate it. A follow-up study found that being a current smoker raised the risk of quitting by 80%, having an enlarged prostate by 74% and believing that bladder medication caused side effects by 111%.
The American Dental Association today praised a Food and Drug Administration advisory panel's finding that the FDA acted appropriately when it ruled last year that dental amalgam is a safe and effective treatment option for the general population.
On October 24, 2019, cystic fibrosis (CF) patients rejoiced at the news that three years of talks between the UK's National Institute for Health and Care Excellence (NICE) and Vertex Pharmaceuticals had succeeded in a compromise which could see about 5,000 patients gaining access to a potentially life-saving drug called Orkambi within the next month. Orkambi is perceived to be a ‘wonder drug' because it helps these patients to breathe easier and better, and can be started as young as two years.
› Verified 7 days ago
| Entity Name | Pratt Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275570319 PECOS PAC ID: 3375515661 Enrollment ID: O20040807000255 |
News Archive
As increased regulatory compliance and pay-for-performance models are leading to higher requirements for electronic data collection and professional fee billing of surgery-related procedures, Merge Healthcare, has responded with new anesthesia information management solutions (AIMS), which will be on display at the American Society of Anesthesiologists (ASA) 2009 Annual Meeting.
Study of 5,392 adults found that a quarter had quit their overactive bladder medication, with nine out of ten saying it didn't work as expected or they couldn't tolerate it. A follow-up study found that being a current smoker raised the risk of quitting by 80%, having an enlarged prostate by 74% and believing that bladder medication caused side effects by 111%.
The American Dental Association today praised a Food and Drug Administration advisory panel's finding that the FDA acted appropriately when it ruled last year that dental amalgam is a safe and effective treatment option for the general population.
On October 24, 2019, cystic fibrosis (CF) patients rejoiced at the news that three years of talks between the UK's National Institute for Health and Care Excellence (NICE) and Vertex Pharmaceuticals had succeeded in a compromise which could see about 5,000 patients gaining access to a potentially life-saving drug called Orkambi within the next month. Orkambi is perceived to be a ‘wonder drug' because it helps these patients to breathe easier and better, and can be started as young as two years.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kari E Roberts, MD 800 Washington St # 257, Boston, MA 02111-1552 Ph: (617) 636-5513 | Kari E Roberts, MD 800 Washington St # 257, Boston, MA 02111-1552 Ph: (617) 636-5513 |
News Archive
As increased regulatory compliance and pay-for-performance models are leading to higher requirements for electronic data collection and professional fee billing of surgery-related procedures, Merge Healthcare, has responded with new anesthesia information management solutions (AIMS), which will be on display at the American Society of Anesthesiologists (ASA) 2009 Annual Meeting.
Study of 5,392 adults found that a quarter had quit their overactive bladder medication, with nine out of ten saying it didn't work as expected or they couldn't tolerate it. A follow-up study found that being a current smoker raised the risk of quitting by 80%, having an enlarged prostate by 74% and believing that bladder medication caused side effects by 111%.
The American Dental Association today praised a Food and Drug Administration advisory panel's finding that the FDA acted appropriately when it ruled last year that dental amalgam is a safe and effective treatment option for the general population.
On October 24, 2019, cystic fibrosis (CF) patients rejoiced at the news that three years of talks between the UK's National Institute for Health and Care Excellence (NICE) and Vertex Pharmaceuticals had succeeded in a compromise which could see about 5,000 patients gaining access to a potentially life-saving drug called Orkambi within the next month. Orkambi is perceived to be a ‘wonder drug' because it helps these patients to breathe easier and better, and can be started as young as two years.
› Verified 7 days ago
Kaitlyn My-tu Lam, MBBS Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-724-7738 | |
Kui Toh Gerard Leong, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 55 Fruit Street, Massachusetts General Hospital, Boston, MA 02114 Phone: 617-726-8862 | |
Ruma Rajbhandari, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 75 Francis St, Boston, MA 02115 Phone: 617-525-6841 | |
Alaka Ray, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-726-2066 | |
Meghan E Sise, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-726-2862 | |
Aaron Dickstein, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 800 Washington St, Box 233, Boston, MA 02111 Phone: 617-636-5883 Fax: 617-636-9292 | |
Dr. Felicia Elizabeth Patch, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 801 Massachusetts Ave, Crosstown 2, Boston, MA 02118 Phone: 617-414-4376 Fax: 617-414-4676 |